Dr MATHIJS Zissi Endocrino-diabetologue
0834.863.162 · rovalta.com · 28/09/2026
Dr MATHIJS Zissi Endocrino-diabetologue
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr MATHIJS Zissi Endocrino-diabetologue is a Private limited company incorporated in 2011. Its main activity is: Specialist medical practice activities. Its registered office is in Le Roeulx.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0834.863.162
- Incorporation
- 25/03/2011
- Legal form
- Private limited company
- Registered office
- Chaussée de Mons(R) 90
7070 Le Roeulx · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 284,3 k € | -18.6% | 349,3 k € | +85.7% | 188,1 k € | -0.4% | 188,9 k € | +2.5% | 184,4 k € |
| EBITDA | 284,3 k € | -18.6% | 349,3 k € | +85.7% | 188,1 k € | -0.4% | 188,9 k € | +2.5% | 184,4 k € |
| Operating result | 251,1 k € | -22.0% | 321,9 k € | +89.8% | 169,5 k € | -0.9% | 171,1 k € | +3.0% | 166,1 k € |
| Net result | 170,5 k € | -17.7% | 207,3 k € | +67.0% | 124,1 k € | +7.3% | 115,6 k € | +3.0% | 112,3 k € |
| Balance sheet | |||||||||
| Equity | 626,2 k € | +31.6% | 475,7 k € | +59.4% | 298,5 k € | +22.1% | 244,4 k € | +36.0% | 179,8 k € |
| Total assets | 779,6 k € | +10.1% | 708,3 k € | +61.7% | 438,1 k € | +9.3% | 400,8 k € | +18.6% | 337,9 k € |
| Cash | 156,5 k € | +86.9% | 83,7 k € | +345% | 18,8 k € | -92.0% | 236,2 k € | +49.0% | 158,5 k € |
| Debts | 153,4 k € | -34.0% | 232,5 k € | +66.6% | 139,6 k € | -10.7% | 156,4 k € | -1.1% | 158,2 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Zissi Mathijs | Mandate |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/04/2026 | 26/06/2025 | 15/07/2024 | 03/07/2023 | 15/07/2022 | 19/07/2021 |
| General meeting | 04/04/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 30/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 04/04/2026 | 15/04/2026 | Dutch | |
| Abridged model | 31/12/2024 | 06/06/2025 | 26/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 07/06/2024 | 15/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 02/06/2023 | 03/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/06/2022 | 15/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 04/06/2021 | 19/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 07/08/2020 | 01/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 24/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 29/06/2018 | 20/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 24/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 23/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 24/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 24/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 21/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/06/2012 | 30/08/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Zissi Mathijs | Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Chaussée de Mons(R) 90, 7070 Le RoeulxCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00079601 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr MATHIJS Zissi Endocrino-diabetologueCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00079601 |
Events
- 2025Annual accounts 2025170,5 k €↓
- 2024Annual accounts 2024207,3 k €↑
- 2023Annual accounts 2023124,1 k €↑
- 2022Annual accounts 2022115,6 k €↑
- 2021Annual accounts 2021112,3 k €↑
- 2020Annual accounts 202056,4 k €↑
- 2019Annual accounts 201943,8 k €↑
- 2018Annual accounts 201835,4 k €↓
- 2017Annual accounts 201779,5 k €↓
- 2016Annual accounts 201683,9 k €↑
- 2015Annual accounts 201577,1 k €↓
- 2014Annual accounts 2014101,3 k €↓
- 2013Annual accounts 2013150,6 k €↑
- 2012Annual accounts 2012140,3 k €↑
- 2011Annual accounts 2011-15,4 k €
- 25/03/2011IncorporationPrivate limited company